Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An update from Cordlife Group ( (SG:P8A) ) is now available.
Cordlife Group Limited has announced an enhanced package for customers affected by the storage of cord blood units in damaged and high-risk tanks. The enhanced package includes a five-year extension of free storage until the child turns 26 and a standardized warranty clause offering up to S$50,000 in damages if a cord blood unit is deemed non-viable due to the company’s negligence. This move aims to address customer concerns and improve trust, with 57% of affected customers having already accepted the company’s resolution offer.
More about Cordlife Group
Cordlife Group Limited is a company registered in Singapore, operating in the healthcare industry with a focus on cord blood banking services. The company provides storage solutions for cord blood units, which are crucial for medical treatments such as transplants.
Average Trading Volume: 133,328
Technical Sentiment Signal: Buy
Current Market Cap: S$68.93M
See more insights into P8A stock on TipRanks’ Stock Analysis page.